Definitive Operating Cash Flow Sales Ratio from 2010 to 2024

DH Stock  USD 7.03  0.04  0.57%   
Definitive Healthcare's Operating Cash Flow Sales Ratio is decreasing with slightly volatile movements from year to year. Operating Cash Flow Sales Ratio is estimated to finish at 0.20 this year. For the period between 2010 and 2024, Definitive Healthcare, Operating Cash Flow Sales Ratio quarterly trend regression had mean deviation of  0.03 and range of 0.1008. View All Fundamentals
 
Operating Cash Flow Sales Ratio  
First Reported
2010-12-31
Previous Quarter
0.16383271
Current Value
0.2
Quarterly Volatility
0.03997493
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Definitive Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Definitive main balance sheet or income statement drivers, such as Depreciation And Amortization of 57.6 M, Interest Expense of 16.7 M or Selling General Administrative of 35.5 M, as well as many exotic indicators such as Price To Sales Ratio of 4.24, Dividend Yield of 0.0115 or PTB Ratio of 1.24. Definitive financial statements analysis is a perfect complement when working with Definitive Healthcare Valuation or Volatility modules.
  
This module can also supplement Definitive Healthcare's financial leverage analysis and stock options assessment as well as various Definitive Healthcare Technical models . Check out the analysis of Definitive Healthcare Correlation against competitors.

Latest Definitive Healthcare's Operating Cash Flow Sales Ratio Growth Pattern

Below is the plot of the Operating Cash Flow Sales Ratio of Definitive Healthcare Corp over the last few years. It is Definitive Healthcare's Operating Cash Flow Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Definitive Healthcare's overall financial position and show how it may be relating to other accounts over time.
Operating Cash Flow Sales Ratio10 Years Trend
Slightly volatile
   Operating Cash Flow Sales Ratio   
       Timeline  

Definitive Operating Cash Flow Sales Ratio Regression Statistics

Arithmetic Mean0.23
Geometric Mean0.22
Coefficient Of Variation17.65
Mean Deviation0.03
Median0.25
Standard Deviation0.04
Sample Variance0
Range0.1008
R-Value(0.77)
Mean Square Error0.0007
R-Squared0.60
Significance0.0007
Slope(0.01)
Total Sum of Squares0.02

Definitive Operating Cash Flow Sales Ratio History

2022 0.16
2021 0.15
2020 0.2

About Definitive Healthcare Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Definitive Healthcare income statement, its balance sheet, and the statement of cash flows. Definitive Healthcare investors use historical funamental indicators, such as Definitive Healthcare's Operating Cash Flow Sales Ratio, to determine how well the company is positioned to perform in the future. Although Definitive Healthcare investors may use each financial statement separately, they are all related. The changes in Definitive Healthcare's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Definitive Healthcare's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Definitive Healthcare Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Definitive Healthcare. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Cash Flow Sales Ratio 0.16  0.20 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Definitive Healthcare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Definitive Healthcare's short interest history, or implied volatility extrapolated from Definitive Healthcare options trading.

Pair Trading with Definitive Healthcare

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Definitive Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Definitive Healthcare will appreciate offsetting losses from the drop in the long position's value.

Moving together with Definitive Stock

  0.77GH Guardant Health Earnings Call This WeekPairCorr
  0.83LH LaboratoryPairCorr

Moving against Definitive Stock

  0.75ESTA Establishment Labs Earnings Call This WeekPairCorr
  0.72DXCM DexCom IncPairCorr
  0.68EDAP EDAP TMS SA Financial Report 15th of May 2024 PairCorr
  0.68EUDA EUDA Health HoldingsPairCorr
  0.58WORX Scworx CorpPairCorr
The ability to find closely correlated positions to Definitive Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Definitive Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Definitive Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Definitive Healthcare Corp to buy it.
The correlation of Definitive Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Definitive Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Definitive Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Definitive Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Definitive Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Definitive Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Definitive Healthcare Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Definitive Healthcare Corp Stock:
Check out the analysis of Definitive Healthcare Correlation against competitors.
Note that the Definitive Healthcare information on this page should be used as a complementary analysis to other Definitive Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for Definitive Stock analysis

When running Definitive Healthcare's price analysis, check to measure Definitive Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Definitive Healthcare is operating at the current time. Most of Definitive Healthcare's value examination focuses on studying past and present price action to predict the probability of Definitive Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Definitive Healthcare's price. Additionally, you may evaluate how the addition of Definitive Healthcare to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is Definitive Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Definitive Healthcare. If investors know Definitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.79)
Revenue Per Share
2.23
Quarterly Revenue Growth
0.088
Return On Assets
(0.01)
Return On Equity
(0.22)
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Definitive Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Definitive Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Definitive Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.